Genesee Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Sell |
2,370
-126
| -5% | -$23.4K | 0.2% | 80 |
|
|
2025
Q1 | $523K | Buy |
2,496
+177
| +8% | +$37.1K | 0.26% | 78 |
|
|
2024
Q4 | $412K | Buy |
2,319
+18
| +0.8% | +$3.2K | 0.19% | 84 |
|
|
2024
Q3 | $454K | Buy |
2,301
+15
| +0.7% | +$2.96K | 0.22% | 82 |
|
|
2024
Q2 | $392K | Buy |
2,286
+166
| +8% | +$28.5K | 0.19% | 81 |
|
|
2024
Q1 | $386K | Buy |
2,120
+240
| +13% | +$43.7K | 0.21% | 79 |
|
|
2023
Q4 | $291K | Buy |
1,880
+482
| +34% | +$74.7K | 0.18% | 83 |
|
|
2023
Q3 | $208K | Buy |
+1,398
| New | +$208K | 0.15% | 84 |
|
|
2023
Q2 | – | Sell |
-1,713
| Closed | -$273K | – | 89 |
|
|
2023
Q1 | $273K | Buy |
+1,713
| New | +$273K | 0.19% | 71 |
|
|
2022
Q4 | – | Sell |
-2,496
| Closed | -$335K | – | 80 |
|
|
2022
Q3 | $335K | Buy |
2,496
+183
| +8% | +$24.6K | 0.26% | 64 |
|
|
2022
Q2 | $354K | Buy |
2,313
+20
| +0.9% | +$3.06K | 0.25% | 70 |
|
|
2022
Q1 | $372K | Buy |
2,293
+184
| +9% | +$29.9K | 0.19% | 79 |
|
|
2021
Q4 | $286K | Buy |
2,109
+22
| +1% | +$2.98K | 0.14% | 88 |
|
|
2021
Q3 | $225K | Buy |
+2,087
| New | +$225K | 0.11% | 103 |
|
|
2021
Q2 | – | Sell |
-2,044
| Closed | -$221K | – | 44 |
|
|
2021
Q1 | $221K | Buy |
2,044
+24
| +1% | +$2.6K | 0.13% | 82 |
|
|
2020
Q4 | $216K | Buy |
+2,020
| New | +$216K | 0.14% | 75 |
|
|
2020
Q3 | – | Sell |
-9,655
| Closed | -$947K | – | 76 |
|
|
2020
Q2 | $947K | Buy |
+9,655
| New | +$947K | 0.88% | 38 |
|